• Create the Future to Overcome Cancer

 

News

2025/01/17
Publishment of a newspaper article about the " Bio IR Day" hosted by the Nihon Securities Journal Inc. covered Noile-Immune (This article was written by only Japanese, Sorry for your inconvenience)
A newspaper article about the " Bio IR Day", company briefing sessions for individual investors, hosted by the Nihon Securities Journal Inc. held on Tuesday, December 10, covered Noile-Immune was published.
2024/12/16
(Correction) Partial Correction to “Notice of Re-prioritization of In-house Drug Discovery Pipelines and Change in Use of Funds Raised at the Time of Listing” (Japanese version already released on October 11)
2024/11/19
Noile-Immune's Director, Tsutom Tokashiki, will participate in a "Company Presentation (Part 3 :14:10-14:45)" and a "Panel Discussion (Part 4 :15:00-16:00)" at the "<Osaka> Bio IR Day" (at Asahi Seimei Hall (Osaka Asahi Seimei Kan 8F)) hosted by the Nihon Securities Journal Inc. on Tuesday, December 10. Reference Link is Japanese only, we're sorry for your inconvenience.
Reference Link is Japanese only, we're sorry for your inconvenience.
2024/11/11
Poster Presentation at SITC Quantitative Clinical Pharmacology and Mechanistic Modeling in a Phase I Clinical Trial of CAR-T Cell Therapy (NIB102) with Noile-Immune’s PRIME Technology
2024/10/28
Presentation at the Annual Meeting of Japan Society of Clinical Oncology (JSCO) Updated Results from First-in-Human Phase I Dose-Escalation Trial of CAR-T Cell Therapy (NIB102) with Noile-Immune’s PRIME Technology